Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gow

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
World Journal of Hepatology|August 8, 2019
Epidemiology and outcomes of acute liver failure in AustraliaPenelope Hey, Timothy P Hanrahan, Marie Sinclair, et al.
Hepatology (Baltimore, Md.)|October 6, 2015
Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is neededThai P Hong, Paul Gow, Michael Fink, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2024
Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in AustraliaEmily Nash, Amanda Nicoll, Nicholas Batt, et al.
American Journal of Medical Genetics. Part A|June 5, 2021
Expanding the clinical and radiological phenotypes of leukoencephalopathy due to biallelic HMBS mutationsChloe A Stutterd, Alexa Kidd, Chris Florkowski, et al.
Transplantation Direct|April 20, 2023
The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New ZealandJess Howell, Avik Majumdar, Michael Fink, et al.
Alimentary Pharmacology & Therapeutics|April 12, 2019
Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levelsAmanda J Nicoll, Stuart K Roberts, Ricky Lim, et al.
The Lancet. Haematology|December 3, 2017
Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trialSim Y Ong, Lyle C Gurrin, Lara Dolling, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 2, 2025
Abdominal aortic calcification on routine preoperative computed tomography-A novel cardiovascular risk prediction tool in liver transplant patientsBenjamin Cailes, Numan Kutaiba, Omar Farouque, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 8, 2021
Turning the Tide on Hepatitis C Virus-Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New ZealandJess Howell, Avik Majumdar, Michael A Fink, et al.
BMJ Open|August 14, 2015
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)Sim Yee Ong, Lara Dolling, Jeannette L Dixon, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
World Journal of Hepatology|August 8, 2019
Epidemiology and outcomes of acute liver failure in AustraliaPenelope Hey, Timothy P Hanrahan, Marie Sinclair, et al.
Hepatology (Baltimore, Md.)|October 6, 2015
Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is neededThai P Hong, Paul Gow, Michael Fink, et al.
Alimentary Pharmacology & Therapeutics|February 19, 2024
Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in AustraliaEmily Nash, Amanda Nicoll, Nicholas Batt, et al.
American Journal of Medical Genetics. Part A|June 5, 2021
Expanding the clinical and radiological phenotypes of leukoencephalopathy due to biallelic HMBS mutationsChloe A Stutterd, Alexa Kidd, Chris Florkowski, et al.
Transplantation Direct|April 20, 2023
The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New ZealandJess Howell, Avik Majumdar, Michael Fink, et al.
Alimentary Pharmacology & Therapeutics|April 12, 2019
Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levelsAmanda J Nicoll, Stuart K Roberts, Ricky Lim, et al.
The Lancet. Haematology|December 3, 2017
Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trialSim Y Ong, Lyle C Gurrin, Lara Dolling, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 2, 2025
Abdominal aortic calcification on routine preoperative computed tomography-A novel cardiovascular risk prediction tool in liver transplant patientsBenjamin Cailes, Numan Kutaiba, Omar Farouque, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 8, 2021
Turning the Tide on Hepatitis C Virus-Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New ZealandJess Howell, Avik Majumdar, Michael A Fink, et al.
BMJ Open|August 14, 2015
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)Sim Yee Ong, Lara Dolling, Jeannette L Dixon, et al.
Pageof 9